Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bluemtec Co's annualized net income for the quarter that ended in Mar. 2024 was ₩-7,370 Mil. Bluemtec Co's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ₩44,158 Mil. Therefore, Bluemtec Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was -16.69%.
The historical rank and industry rank for Bluemtec Co's Return-on-Tangible-Equity or its related term are showing as below:
XKRX:439580'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -13.27 Med: 0 Max: 0
Current: -13.27
XKRX:439580's Return-on-Tangible-Equity is ranked worse than 79.34% of 542
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs XKRX:439580: -13.27
Bluemtec Co Return-on-Tangible-Equity Historical Data
The historical data trend for Bluemtec Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bluemtec Co's Return-on-Tangible-Equity
For the Pharmaceutical Retailers subindustry, Bluemtec Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bluemtec Co's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bluemtec Co's Return-on-Tangible-Equity falls into.
Bluemtec Co Return-on-Tangible-Equity Calculation
Bluemtec Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Bluemtec Co (XKRX:439580) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bluemtec Co Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Bluemtec Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:439580 has been successfully added to your